Asthma remains one of the leading chronic conditions worldwide, cutting across age groups and demographics. Despite advances in treatment and awareness, the prevalence of asthma continues to climb in many regions. This rise underscores the growing demand for innovative therapies. The expanding bronchial hyperreactivity market signals how pressing the need has become. While inhalers remain a...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Русский
Română
Português
Ελληνικά
Tiếng Việt